Catalyst Wire Dossier Catalyst Wire Dossier

KR230109 Cream

· Jiangxi Kvvit Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KR230109 Cream, covering 2026-01-15 to 2026-01-15. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Efficacy and Pharmacokinetic Characteristics of KR230109 Cream in Facial Acne Vulgaris [Phase 2]

See pricing